Stay updated on AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.

Latest updates to the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a minor system revision from v3.4.1 to v3.4.2 with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1; no substantive changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedGlossary toggle options (Show glossary / Hide glossary) were added, and the footer now shows Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Previously, the footer displayed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.3%

- Check40 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. This is a minor update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedNew locations have been added under Contacts and Locations, listing Arizona, California, Colorado, Florida, Massachusetts, Missouri, New York, Oregon, Pennsylvania, and Texas. The page shows revision v3.3.3 and removes the prior per-state location subsections and the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check90 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. This appears to be a maintenance update with no changes to trial data or eligibility.SummaryDifference0.1%

Stay in the know with updates to AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.